KIRA8 attenuates non-alcoholic steatohepatitis through inhibition of the IRE1alpha/XBP1 signalling pathway. Zhao S, Liu X, Li L, Kong X, et al. Biochem Biophys Res Commun 2022;632:158-164.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao S, Liu X, Li L, Kong X, et al. KIRA8 attenuates non-alcoholic steatohepatitis through inhibition of the IRE1alpha/XBP1 signalling pathway. Biochem Biophys Res Commun 2022;632:158-164.
PMID: 36209584